Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
35,452,360
-
Shares change
-
+24,630,337
-
Total reported value, excl. options
-
$224,051,807
-
Value change
-
+$172,782,844
-
Put/Call ratio
-
84%
-
Number of buys
-
66
-
Number of sells
-
-26
-
Price
-
$6.32
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2021
116 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q2 2021.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,452,360 shares
of 129,337,627 outstanding shares and own 27.41% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,954,281 shares), VANGUARD GROUP INC (5,762,626 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2,592,177 shares), STATE STREET CORP (2,032,668 shares), GEODE CAPITAL MANAGEMENT, LLC (1,968,745 shares), Invesco Ltd. (1,851,353 shares), MILLENNIUM MANAGEMENT LLC (1,666,911 shares), GROUP ONE TRADING, L.P. (1,644,488 shares), JANE STREET GROUP, LLC (1,323,649 shares), and NORTHERN TRUST CORP (1,123,852 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.